Diabetic Foot Ulcer Treatment Market Regional Analysis:
North American Market Insights
North America region is poised to dominate around 38.8% market share by 2035, driven by rising peripheral neuropathy cases among diabetics and increasing treatment options for ulcer diagnosis. Among these segments, the neuropathic ulcer segment is anticipated to capture the largest market size in the global diabetic foot ulcer treatment market owing to an increase in peripheral neuropathy cases among diabetics. It was observed that approximately 48% of diabetic patients experience peripheral neuropathy at some point in their lives, with prevalence ranging from 7% to 50% based on factors such as diabetes type and glycemic control. Furthermore, the number of risks associated with neuropathic ulcers, such as infection, amputation, and death, and increasing treatment options for ulcer diagnosis is projected to augment segment growth over the forecast period.
APAC Market Insights
The Asia Pacific diabetic foot ulcer treatment market is projected to register substantial growth till 2035. The market growth in the region is expected on the account of a rise in the number of patients suffering from diabetes. According to the World Health Organization around 77 million Indians over the age of 18 have type 2 diabetes, and over 25 million are prediabetics More than 50% of people do not know they have diabetes, which can cause serious health problems if not diagnosed timely and not provided with adequate treatment.
